PubRank

F H Derkx

Author PubWeight™ 109.64‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000 4.81
2 Cystatin for estimation of glomerular filtration rate? Lancet 2000 2.80
3 Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000 2.29
4 Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension 1994 1.87
5 Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521. Br J Clin Pharmacol 1982 1.81
6 Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. Br J Ophthalmol 1996 1.74
7 Volume regulation in children with early relapse of minimal-change nephrosis with or without hypovolaemic symptoms. Lancet 1995 1.56
8 Do older hospital patients recognize adverse drug reactions? Age Ageing 2000 1.49
9 Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997 1.45
10 Support for adrenaline-hypertension hypothesis: 18 hour pressor effect after 6 hours adrenaline infusion. Lancet 1988 1.40
11 Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 1997 1.40
12 [Hypertension caused by arterial fibromuscular dysplasia]. Ned Tijdschr Geneeskd 1994 1.39
13 Angiotensin levels in the eye. Invest Ophthalmol Vis Sci 1994 1.36
14 Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J Clin Endocrinol Metab 1989 1.35
15 Opposite effects of captopril on angiotensin I-converting enzyme 'activity' and 'concentration'; relation between enzyme inhibition and long-term blood pressure response. Clin Sci (Lond) 1981 1.31
16 Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens 1998 1.28
17 Adverse drug reactions in elderly patients as contributing factor for hospital admission: cross sectional study. BMJ 1997 1.27
18 Angiotensin I-to-II conversion in the human renal vascular bed. J Hypertens 1998 1.26
19 Inactive renin in human plasma. Lancet 1976 1.22
20 Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects. Br Med J 1980 1.17
21 Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus. Diabetologia 1999 1.14
22 Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. Hypertension 1997 1.14
23 Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. Am J Clin Nutr 1994 1.09
24 Activation of inactive plasma renin by plasma and tissue kallikreins. Clin Sci (Lond) 1979 1.09
25 Identification and quantification of renin and prorenin in the bovine eye. Endocrinology 1990 1.08
26 Control of enzymatically inactive renin in man under various pathological conditions: implications for the interpretation of renin measurements in peripheral and renal venous plasma. Clin Sci Mol Med 1978 1.07
27 Effects of selective and nonselective beta-agonists on plasma potassium and norepinephrine. J Cardiovasc Pharmacol 1984 1.06
28 Splint renal function after captopril in unilateral renal artery stenosis. Br Med J (Clin Res Ed) 1984 1.04
29 Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response? J Hypertens 1992 1.01
30 Asynchronous changes in prorenin and renin secretion after captopril in patients with renal artery stenosis. Hypertension 1983 1.00
31 Pharmacological interaction between pancuronium bromide and anaesthetics. Eur J Pharmacol 1968 0.98
32 Uptake and proteolytic activation of prorenin by cultured human endothelial cells. J Hypertens 1999 0.98
33 An intrinsic factor XII- prekallikrein-dependent pathway activates the human plasma renin-angiotensin system. Nature 1979 0.98
34 Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension 1990 0.94
35 Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin Sci (Lond) 1995 0.94
36 High plasma prorenin in diabetes mellitus and its correlation with some complications. J Clin Endocrinol Metab 1990 0.93
37 DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin? J Hypertens Suppl 1983 0.93
38 Clinical pharmacokinetics: a comprehensive system for therapeutic drug monitoring and prescribing. Br Med J (Clin Res Ed) 1984 0.90
39 Haemodynamic profile of captopril treatment in various forms of hypertension. Eur J Clin Pharmacol 1981 0.89
40 Endothelin and active renin levels in essential hypertension and hypertension with renal artery stenosis before and after percutaneous transluminal renal angioplasty. J Hypertens 1997 0.89
41 Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives. J Clin Endocrinol Metab 1986 0.89
42 Metabolism of angiotensin I by different tissues in the intact animal. Am J Physiol 1992 0.89
43 Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents. N Engl J Med 1991 0.88
44 Species-dependent effect of neuromuscular blocking agents. Eur J Pharmacol 1971 0.88
45 High-affinity prorenin binding to cardiac man-6-P/IGF-II receptors precedes proteolytic activation to renin. Am J Physiol Heart Circ Physiol 2001 0.88
46 The place of renal scintigraphy in the diagnosis of renal artery stenosis. Fifteen years of clinical experience. Arch Intern Med 1997 0.88
47 Captopril affects blood pressure equally in renovascular and essential hypertension and in the fluid-depleted anephric state. Clin Sci (Lond) 1980 0.87
48 Role of plasma kallikrein in the proteolytic activation of the renin-angiotensin system. Clin Exp Hypertens 1980 0.86
49 Prolonged blood pressure reduction by orally active renin inhibitor RO 42-5892 in essential hypertension. BMJ 1990 0.86
50 Prorenin, renin, angiotensinogen, and angiotensin-converting enzyme in normal and failing human hearts. Evidence for renin binding. Circulation 1997 0.85
51 High concentrations of immunoreactive renin, prorenin and enzymatically-active renin in human ovarian follicular fluid. Br J Obstet Gynaecol 1987 0.85
52 Production of angiotensins I and II at tissue sites in intact pigs. Am J Physiol 1992 0.85
53 Prorenin accumulation and activation in human endothelial cells: importance of mannose 6-phosphate receptors. Arterioscler Thromb Vasc Biol 2001 0.84
54 Association of high plasma prorenin with diabetic retinopathy. J Hypertens Suppl 1988 0.84
55 Source of plasma prorenin in early and late pregnancy: observations in a patient with primary ovarian failure. J Clin Endocrinol Metab 1987 0.83
56 Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME. Am J Physiol 1998 0.83
57 Regional angiotensin II production in essential hypertension and renal artery stenosis. Hypertension 1993 0.83
58 Cardiomyocytes bind and activate native human prorenin : role of soluble mannose 6-phosphate receptors. Hypertension 2001 0.83
59 Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels. J Hypertens 1998 0.82
60 'Hypertension resistant to two-drug treatment' is a useful criterion to select patients for angiography: the 'Dutch Renal Artery Stenosis Intervention Cooperative' (DRASTIC) study. Contrib Nephrol 1996 0.82
61 Who should be converted from cyclosporine to conventional immunosuppression in kidney transplantation, and why. Transplantation 1987 0.82
62 Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy. Nephrol Dial Transplant 1999 0.82
63 Two-step prorenin-renin conversion. Isolation of an intermediary form of activated prorenin. J Biol Chem 1987 0.81
64 The clinical pharmacology of bopindolol, a new long-acting beta-adrenoceptor antagonist, in hypertension. Clin Pharmacol Ther 1987 0.81
65 Optimising glomerular filtration rate and effective renal plasma flow measurements using a simple pharmacokinetic model. Clin Nephrol 1995 0.81
66 ACTH-dependent aldosterone excess due to adrenocortical adenoma: a variant of primary aldosteronism. J Clin Endocrinol Metab 1978 0.81
67 Glomerular hyperfiltration in insulin-dependent diabetes mellitus is correlated with enhanced growth hormone secretion. J Clin Endocrinol Metab 1993 0.81
68 Resistance to antihypertensive medication as predictor of renal artery stenosis: comparison of two drug regimens. J Hum Hypertens 2001 0.81
69 Plasma prorenin as an early marker of microvascular disease in patients with diabetes mellitus. Diabete Metab 1992 0.81
70 Twenty-four hour pressor effect of infused adrenaline in normotensive subjects: a randomized controlled double-blind cross-over study. J Hypertens Suppl 1988 0.80
71 Estimation of regional metabolism and production of angiotensins in hypertensive subjects. Br J Clin Pharmacol 1989 0.80
72 A mutant renin gene in familial elevation of prorenin. J Biol Chem 1994 0.80
73 Risks of angiotensin converting enzyme inhibition in renal artery stenosis. Kidney Int Suppl 1987 0.80
74 Inter-observer variability in the angiographic assessment of renal artery stenosis. DRASTIC study group. Dutch Renal Artery Stenosis Intervention Cooperative. J Hypertens 1999 0.79
75 Activation of inactive plasma renin by tissue kallikreins. J Clin Endocrinol Metab 1979 0.79
76 Atrial wall stress rather than pressure per se might be responsible for the increased secretion of atrial natriuretic factor after heart transplantation. J Hypertens Suppl 1988 0.79
77 The inability of propranolol and aspirin to inhibit the response of fibrinolytic activity and factor VIII-antigen to infusion of DDAVP. Thromb Haemost 1984 0.79
78 Intrarenal de novo production of angiotensin I in subjects with renal artery stenosis. Hypertension 1990 0.79
79 Plasma kallikrein-mediated activation of the renin-angiotensin system does not require prior acidification of prorenin. J Clin Endocrinol Metab 1982 0.79
80 Acute and long-term effects of acebutolol on systemic and renal hemodynamics, body fluid volumes, catecholamines, active renin, aldosterone, and lymphocyte beta-adrenoceptor density. J Cardiovasc Pharmacol 1988 0.79
81 Cardioprotection by blockade of beta 2-adrenoceptors. Eur Heart J 1983 0.78
82 Improved immunoradiometric assay for plasma renin. Clin Chem 1999 0.78
83 Normal homeostasis of fibrinolysis in nephrogenic diabetes insipidus in spite of defective V2- receptor-mediated responses of tissue plasminogen activator release. Eur J Clin Invest 1990 0.78
84 Diurnal variation in prorenin in relation to other humoral factors and hemodynamics. Am J Hypertens 1994 0.78
85 Changes in plasma renin and angiotensin run in parallel after nephrectomy. J Hypertens Suppl 1993 0.78
86 Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man. Thromb Haemost 1988 0.78
87 Hemodynamic effects of captopril in essential hypertension, renovascular hypertension and cardiac failure: correlations with short- and long-term effects on plasma renin. Am J Cardiol 1982 0.78
88 Effect of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus. J Am Soc Nephrol 1995 0.78
89 Is beta 1-antagonism essential for the antihypertensive action of beta-blockers? Hypertension 1987 0.77
90 Release of active and inactive renin by the pig kidney during development. Dev Pharmacol Ther 1980 0.77
91 Cardiac renin is kidney-derived. J Hypertens Suppl 1993 0.77
92 In vivo production of plasma angiotensin I: is plasma renin sufficient? J Hypertens Suppl 1989 0.77
93 Probing epitopes on human prorenin during its proteolytic and non-proteolytic activation. Biochim Biophys Acta 1998 0.77
94 Increase in plasma prorenin during the menstrual cycle of a bilaterally nephrectomized woman. Br J Obstet Gynaecol 1990 0.77
95 Angiotensin II production in different vascular beds in hypertensive subjects. J Hypertens Suppl 1991 0.77
96 Absence of activation in vitro of renin in rat plasma. Clin Sci (Lond) 1982 0.77
97 Effect of long-acting somatostatin analog (Somatulin) on renal hyperfiltration in patients with IDDM. Diabetes Care 1997 0.77
98 Assessment of the role of the renin-angiotensin system in cardiac contractility utilizing the renin inhibitor remikiren. Br J Pharmacol 1996 0.77
99 Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension. J Hypertens 1993 0.76
100 Plasma kallikrein and plasmin as activators of prorenin: links between the renin-angiotensin system and other proteolytic systems in plasma. Clin Sci (Lond) 1981 0.76
101 Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system. J Hypertens Suppl 1992 0.76
102 Renin in the bovine eye. J Hypertens Suppl 1989 0.76
103 Recurrence of hypertension in primary aldosteronism after discontinuation of spironolactone. Time course of changes in cardiac output and body fluid volumes. Clin Exp Hypertens A 1982 0.76
104 Elevated plasma levels of endothelin in pre-eclampsia. J Hypertens Suppl 1991 0.76
105 The effects of lead on the renin-angiotensin system. Xenobiotica 1985 0.76
106 Evaluation of a microcomputer program (OPT) for parameter optimisation in clinical pharmacokinetics: gentamicin and tobramycin. Br J Clin Pharmacol 1987 0.75
107 Plasma immunoreactive endothelin-1 in pregnant women with and without pre-eclampsia. J Cardiovasc Pharmacol 1991 0.75
108 More on renin. Clin Chem 1997 0.75
109 Volume-pressure relationships during development of mineralocorticoid hypertension in man. Circ Res 1977 0.75
110 Raised plasma renin and prorenin in rheumatoid vasculitis. Ann Rheum Dis 1990 0.75
111 A neonate with idiopathic hyperaldosteronism. Pediatr Nephrol 1991 0.75
112 Prorenin in vitreous and subretinal fluid of the human eye. Clin Exp Hypertens A 1988 0.75
113 Renal release of active and inactive renin in essential and renovascular hypertension. Clin Sci Mol Med Suppl 1978 0.75
114 Prolonged cyclosporine therapy to induce solid engraftment after renal transplantation. Transplant Proc 1987 0.75
115 Desmopressin and hypotension. Ann Intern Med 1985 0.75
116 The influence of dietary sodium restriction on renal and ovarian renin and prorenin production during ovarian stimulation. Hum Reprod 1996 0.75
117 Activators of inactive renin ("prorenin') in human plasma: their connection with kinin formation, coagulation and fibrinolysis. Clin Sci (Lond) 1979 0.75
118 Evidence for activation of circulating inactive renin by the human kidney. Clin Sci (Lond) 1979 0.75
119 Role of intrinsic inhibitors in acid-activation of inactive plasma renin (prorenin). Clin Exp Hypertens A 1982 0.75
120 Two forms of plasma renin after activation in vitro and their relation to natural plasma renin. Clin Sci (Lond) 1981 0.75
121 High renin and prorenin in plasma and pleural exudate of a patient with the ovarian hyperstimulation syndrome. Neth J Med 1997 0.75
122 [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II]. Ned Tijdschr Geneeskd 1980 0.75
123 Activation of plasma prorenin by plasminogen activators in vitro and increase in plasma renin after stimulation of fibrinolytic activity in vivo. Neth J Med 1984 0.75
124 Changes in plasma renin activity and renal immunohistochemically demonstrated renin in carbadox treated pigs. Res Vet Sci 1989 0.75
125 Prorenin and renal function in NIDDM patients with normo- and microalbuminuria. J Intern Med 1995 0.75
126 Effects of DDAVP on renal hemodynamics and renin secretion in subjects with essential hypertension. Clin Nephrol 1994 0.75
127 Blood pressure response of nephrectomized subjects and patients with essential hypertension to ramipril: indirect evidence that inhibition of tissue angiotensin converting enzyme is important. Am J Cardiol 1987 0.75
128 Theophylline and serum electrolytes. Ann Intern Med 1986 0.75
129 Cyclosporin and the glomerular filtration barrier in minimal change disease and membranous glomerulopathy. Contrib Nephrol 1995 0.75
130 Regional production of angiotensins I and II: contribution of vascular kidney-derived renin. J Hypertens Suppl 1991 0.75
131 Glomerular barrier function following conversion from cyclosporine to azathioprine in renal transplant recipients. Am J Kidney Dis 1994 0.75
132 Activation of plasma prorenin by plasminogen activators in vitro and increase in plasma renin after stimulation of fibrinolytic activity in vivo. Clin Exp Hypertens A 1982 0.75
133 [Routine determination of serum digoxin and theophylline levels; no superfluous luxury]. Ned Tijdschr Geneeskd 1984 0.75
134 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus. Neth J Med 1993 0.75
135 Effects of complete renal denervation and selective afferent renal denervation on the hypertension induced by intrarenal norepinephrine infusion in conscious rats. J Hypertens 1989 0.75
136 Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors. J Lab Clin Med 1984 0.75
137 Renal secretion of inactive renin. Contrib Nephrol 1978 0.75
138 [Digoxin in elderly patients]. Ned Tijdschr Geneeskd 1986 0.75
139 Angiotensin-converting enzyme inhibition does not correct early defects in renal and vascular permeability in diabetes mellitus. Clin Sci (Lond) 1998 0.75
140 The plasma kallikrein-renin connection. Arch Int Pharmacodyn Ther 1980 0.75
141 Captopril-induced changes on active and inactive renin in a patient with factor XII congenital deficiency. Res Exp Med (Berl) 1985 0.75
142 Recurrence of phaeochromocytoma, with development of metastases. Effect of treatment with alpha-methylparatyrosine. Neth J Med 1981 0.75